AF deliberately misleads again. He doesn't say anything about the benefits of an orphan drug designation which include:
Enhanced patent protection and marketing rights.
Clinical research financial subsidization.
Creating a government-run enterprise to engage in research and development
I've seen AF destroy many stocks and he just laughs at the SEC all the way to the bank.